viDA Therapeutics Inc.
PrivateLast Round
Seed
Sep 10, 2015
Total Funding Raised
$6.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
viDA Therapeutics Inc. is a biotechnology company that develops novel, first-in-class drugs for the treatment of inflammatory and autoimmune diseases by targeting granzyme serine proteases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
viDA Therapeutics Inc. Comparables
Compare viDA Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quoin Pharmaceuticals | 76% | |
| ImmuNext, Inc. | 67% | |
| ResVita Bio | 60% |
viDA Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 10, 2015 | ||||
| VC Round | Jul 10, 2013 | ||||
| Seed | Apr 24, 2013 | ||||
| Seed | Jul 28, 2011 |
viDA Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Carmanah Management | Seed |
| BDC Capital | Seed, VC Round |
| Nimbus Synergies | Seed |
| UBC Investment Management | Seed |
| adMare BioInnovations | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 142% MoM, reaching 1.6K.
- Apr 15, 2026
Monthly visitors grew 98% MoM.
viDA Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access